E-LIB Suche - Ergebnisse für: Garner, R. Colin

1

Dose‐linearity of the pharmacokinetics of an intravenous [1..:

van Groen, Bianca D. ; Vaes, Wouter H. ; Park, B. Kevin...
British Journal of Clinical Pharmacology. 85 (2019) 10 - p. 2332-2340 , 2019

Link: https://doi.org/10.1111/..

2

Evaluation of a Library of FDA-Approved Drugs for Their Abi..:

Hind, Charlotte K. ; Dowson, Christopher G. ; Sutton, J. Mark...
Antimicrobial Agents and Chemotherapy. 63 (2019) 8 - p. , 2019

Link: https://doi.org/10.1128/..

3

Observational infant exploratory [14C]‐paracetamol pharmaco..:

Garner, Colin R. ; Park, Kevin B. ; French, Neil S....
British Journal of Clinical Pharmacology. 80 (2015) 1 - p. 157-167 , 2015

Link: https://doi.org/10.1111/..

4

A pharmacokinetic evaluation of five H1 antagonists after a..:

Madan, Ajay ; O'Brien, Zhihong ; Wen, Jianyun...
British Journal of Clinical Pharmacology. 67 (2009) 3 - p. 288-298 , 2009

Link: https://doi.org/10.1111/..

5

Microdose Pharmacokinetics of IDX899 and IDX989, Candidate ..:

Zhou, Xiao‐Jian ; Garner, R. Colin ; Nicholson, Sheila..
The Journal of Clinical Pharmacology. 49 (2009) 12 - p. 1408-1416 , 2009

Link: https://doi.org/10.1177/..

6

A Review of Human Phase 0 (Microdosing) Clinical Trials Fol..:

Lappin, Graham ; Garner, R. Colin
International Journal of Pharmaceutical Medicine. 20 (2006) 3 - p. 159-165 , 2006

Link: https://doi.org/10.2165/..

7

Commentary: The phase 0 microdosing concept:

Garner, R. Colin ; Lappin, Graham
British Journal of Clinical Pharmacology. 61 (2006) 4 - p. 367-370 , 2006

Link: https://doi.org/10.1111/..

8

Current perspectives of 14 C-isotope measurement in biomedi..:

Lappin, Graham ; Garner, R. Colin
Analytical and Bioanalytical Chemistry. 378 (2004) 2 - p. 356-364 , 2004

Link: https://doi.org/10.1007/..

9

Vegetable, fruit and meat consumption and potential risk mo..:

Turner, Faye ; Smith, Gillian ; Sachse, Christoph...
International Journal of Cancer. 112 (2004) 2 - p. 259-264 , 2004

Link: https://doi.org/10.1002/..

10

Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) i..:

Sachse, Christoph ; Bhambra, Upinder ; Smith, Gillian...
British Journal of Clinical Pharmacology. 55 (2003) 1 - p. 68-76 , 2003

Link: https://doi.org/10.1046/..

11

Big physics, small doses: the use of AMS and PET in human m..:

Lappin, Graham ; Garner, R. Colin
Nature Reviews Drug Discovery. 2 (2003) 3 - p. 233-240 , 2003

Link: https://doi.org/10.1038/..

12

Mutations in APC, Kirsten-ras, and p53—alternative genetic ..:

Smith, Gillian ; Carey, Francis A. ; Beattie, Julie...
Proceedings of the National Academy of Sciences. 99 (2002) 14 - p. 9433-9438 , 2002

Link: https://doi.org/10.1073/..

13

Mutations in APC, Kirsten-Ras, and p53-Alternative Genetic ..:

Smith, Gillian ; Carey, Francis A. ; Beattie, Julie...
Proceedings of the National Academy of Sciences of the United States of America. 99 (2002) 14 - p. 9433-9438 , 2002

Link: https://www.jstor.org/st..

14

Macromolecular adduct formation and metabolism of heterocyc..:

Turteltaub, Kenneth W ; Dingley, Karen H ; Curtis, Kellie D...
Cancer Letters. 143 (1999) 2 - p. 149-155 , 1999

Link: https://doi.org/10.1016/..

15

Comparison of DNA-adduct and tissue-available dose levels o..:

Mauthe, Robert J. ; Dingley, Karen H. ; Leveson, Steven H....
International Journal of Cancer. 80 (1999) 4 - p. 539-545 , 1999

Link: https://doi.org/10.1002/..